In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.

British Journal of Clinical Pharmacology - Tập 26 Số 1 - Trang 23-29 - 1988
DJ Back1, John Tjia1, J Karbwang1, J Colbert1
1Department of Pharmacology & Therapeutics, University of Liverpool.

Tóm tắt

1. A number of compounds have been examined for their ability to inhibit tolbutamide hydroxylase activity in human liver microsomes (control value at a substrate concentration of 150 microM being 0.27 +/‐ 0.12 nmol min‐1 mg‐1 protein; mean +/‐ s.d.; n = 7). 2. IC50 (concentration of inhibitor producing 50% inhibition) values were determined for a range of sulphonamides, imidazoles and aminoquinoline compounds. The most potent inhibition was evident with the 1‐ substituted imidazole antimycotic drugs ketoconazole, clotrimazole and miconazole and the sulphonamide sulphaphenazole (IC50 values of 16.5, 2.5, 0.85 and 0.5 microM respectively). A number of compounds showed little or no inhibition of tolbutamide hydroxylase as judged by an IC50 of greater than or equal to 500 microM. 3. The Km value for tolbutamide hydroxylase was 125 microM and Vmax, 0.44 nmol min‐1 mg‐1 protein. All the substituted imidazoles examined in kinetic studies 1v vs 1s, Line‐ weaver‐Burk plots) produced either non‐competitive or mixed inhibition. The sulphonamides exhibited competitive inhibition, the Ki for sulphaphenazole being 0.22 microM. Primaquine showed mixed inhibition. Dixon plots confirmed the type of inhibition produced. 4. Although the competitive inhibition between some sulphonamides and tolbutamide is consistent with metabolism by the same isozyme of cytochrome P‐450 it does not prove it and further studies with purified enzymes will be necessary to confirm this.

Từ khóa


Tài liệu tham khảo

10.1111/j.1365-2125.1983.tb02199.x

10.1111/j.1365-2125.1983.tb02206.x

10.1016/0006-2952(83)90553-1

10.1111/j.1476-5381.1984.tb10109.x

10.1111/j.1476-5381.1985.tb08838.x

10.1007/BF00614553

10.1016/0006-291X(79)91482-7

Beaune P. H., 1986, Comparison of monooxygenase activities and cytoschrome P‐450 isozyme concentrations in human liver microsomes, Drug Metab. Disp., 14, 437

10.1038/clpt.1985.42

10.1002/j.1552-4604.1986.tb03540.x

10.1016/S0140-6736(63)90847-X

Cockburn I., 1986, Cyclosporin A: A clinical evaluation of drug interactions, Transplant Proc, 18, 50

10.1111/j.1365-2125.1983.tb02192.x

Distlerath L. M., 1985, Purification and characterization of the human liver cytochromes P‐450 involved in debrisoquine 4‐hydroxylation and phenacetin‐o‐deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism, J. biol. Chem., 260, 9057, 10.1016/S0021-9258(17)39456-5

10.1042/bj0550170

Guengerich F. P., 1986, Oxidation of quinidine by human liver cytochrome P‐450, Mol. Pharmac., 30, 287

10.3109/00498258709043941

Hall S. D., 1987, Characterization and inhibition of mephenytoin 4‐hydroxylase activity in human liver microsomes, J. Pharmac. exp. Ther., 240, 216

Inaba T., 1985, In vitro inhibition studies of two isozymes of human liver cytochrome P‐450, Drug Metab. Disp., 14, 443

10.1007/BF00541288

Knodell R. G., 1987, Hepatic metabolism of tolbutamide: Characterisation of the form of cytochrome P‐450 involved in methyl hydroxylation and relationship to in vivo disposition, J. Pharmac. exp. Ther., 241, 1112

10.3109/00498258709047174

10.1016/S0021-9258(19)52451-6

10.1002/cpt1975176731

Meredith C. G., 1985, The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro, Drug Metab. Disp., 13, 156

10.1016/0006-2952(85)90040-1

10.1016/0006-2952(84)90090-X

Omura T., 1964, The carbon‐monoxidebinding pigment of liver microsomes, J. biol. Chem., 239, 2370, 10.1016/S0021-9258(20)82244-3

10.1002/cpt1977225part1573

10.1111/j.1365-2125.1987.tb03167.x

10.1111/j.1365-2125.1987.tb03074.x

10.1016/0006-2952(85)90191-1

10.1016/S0009-2797(86)80075-8

10.1007/BF01059791

10.1007/BF00420342

Sheets J. J., 1984, Ketoconazole: A potent inhibitor of cytochrome P‐450 dependent drug metabolism in rat liver, Drug Metab. Disp., 12, 603

10.1016/0006-2952(86)90224-8

10.1007/BF00606666

10.1016/0009-2797(84)90154-6

10.1021/bi00292a019

Webb J. L., 1963, Enzyme and metabolic inhibitors, 149, 10.5962/bhl.title.7320

Thông tin
Thông tin xuất bản

British Journal of Clinical Pharmacology

Tập 26 Số 1

23-29

Thông tin tác giả